Taxotere Lawsuit Information

Saturday September 13, 2025 — Breast cancer patients who experienced permanent hair loss may have grounds to pursue a Taxotere lawsuit.

Over 1,100 Taxotere lawsuits have now been filed in a growing federal litigation with additional cases pending in various state courts around the country.

Plaintiffs allege Taxotere’s manufacturer was aware of the risk of permanent hair loss (or, alopecia) but failed to warn doctors, patients, and government regulators.

If you or a loved one experienced disfiguring hair loss, contact our Taxotere lawyers by phone or online for a free and confidential review of your case.

The Taxotere litigation includes patients treated with generic forms of docetaxel.

Taxotere Hair Loss Lawsuit Allegations

The legal case against Taxotere is based on the following alleged misconduct by the drug’s manufacturer, pharmaceutical giant Sanofi-Aventis:

• Taxotere’s design makes it more toxic than competitor drug Taxol, but fails to improve clinical outcomes for patients.
• A 2008 study published in the New England Journal of Medicine concluded that Taxotere, in fact, proved less effective than Taxol in achieving disease-free and overall survival in women with breast cancer.
• Despite clinical data to the contrary, the manufacturer continued to promote the “superior efficacy” of Taxotere to oncologists.
• As a result, in May 2009, the U.S. Food and Drug Administration issued a warning letter to Sanofi-Aventis. The FDA cautioned the company that its efficacy claims were unsubstantiated, and that its promotional materials were false and misleading under the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. §§ 352(a) and 321(n).
• Further, the company was aware in 2005 of a study known as GEICAM 9805 which found that 9.2% of patients treated with Taxotere experienced prolonged or permanent hair loss.
• The company failed to disclose the risk of permanent alopecia to Taxotere patients in the U.S. until 2015, nearly 20 years after the FDA first approved the drug for sale.
• In its revised prescribing information, the company now states, “Cases of permanent alopecia have been reported.” Under Patient Information, the label provides simply, “In some cases (frequency not known) permanent hair loss has been observed.”

Thus, plaintiffs allege the manufacturer knowingly exposed breast cancer patients to an unnecessary risk of permanent alopecia without greater efficacy of treatment, while at the same time driving Taxotere sales to over $1.4 billion per year.

Taxotere lawsuits set forth the following claims for relief (or, legal counts) against the defendants:

• Negligence
• Failure to Warn
• Fraudulent Concealment
• Fraudulent Misrepresentation
• Design and Manufacturing Defects
• Breach of Express Warranty
• Breach of Implied Warranty
• Intentional Infliction of Emotional Distress
• Violation of Consumer Protection Laws

Is There a Taxotere Class Action Lawsuit?

Taxotere permanent hair loss cases are filed on an individual basis and not as part of a class action proceeding.

This means you will have your own attorney to represent you and guide you through the litigation process.

This also means that if your case is successful, you will be compensated based on the unique legal damages you incurred, such as: medical expenses, lost earnings, pain and suffering, emotional distress, and loss of consortium.

At the same time, your case might be coordinated with other individual Taxotere claims for pretrial purposes. For instance, over 1,100 federal court cases have been centralized in the Eastern District of Louisiana, Taxotere MDL No. 2740.

Though not a Taxotere class action, these coordinated lawsuits allow individual plaintiffs to present a stronger case for liability against the manufacturer.

After a detailed evaluation, your attorney can determine whether to file your case in the centralized Taxotere proceeding or as a separate state court action.

Free Taxotere Lawsuit Case Review

Our lawyers have over 25 years’ experience in defective drug and medical device litigation and serve as national leaders in this complex area of law.

We represent all Taxotere lawsuit clients on a no-fee, contingency basis.

Contact our firm at any time to review your case and learn how we can help.